Overview

Healthcare

Corvina Pharma SA

Corvina Pharma SA

Obligor cp-20 · Healthcare · Spain

Exposure at default

Quarter 2026-Q1

Exposure at default: €106.8m
Committed limit: €119.1m
Drawn: €101.7m
Undrawn: €17.4m
PD: 3.46%
LGD: 46%
Expected loss: €1.7m
Risk-weighted assets: €185.5m
RWA density: 174%

Relationship manager

J. Whitfield

Onboarded: 5 May 2019
Last review: 1 Feb 2026
Next review: 15 Apr 2026
Band: Sub-investment grade
Facilities: 2
Group: None

Facility

Type

Currency

Commitment

EAD

Utilisation

Margin

Maturity

Status

Term loan

EUR

€83.6m

€80.9m

94%

375 bps

22 Jul 2032

Trade finance

EUR

€35.5m

€25.9m

66%

395 bps

10 Apr 2029

Consolidated exposure by group of connected clients